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MANIA IN PARKINSON'S DISEASE WITH TREATMENT . 
EMERGENT DYSKINESIA : A CASE REPORT 
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ABSTRACT 
A case ofparkinson 's disease starting 7 yrs. ago in 1993 with 2 episodes of mania is presented. 
The 1st episode (1993) was of 1-
1A months duration, when early parkinsons symptoms had already 
set in. This was treated with anti-psychotic medications for a month, the picture was complicated 
with stroke and post-stroke sequlae for 5-6 months, where anti-psychotics were continued. He 
developed dyskinesia, when antipsychotics were stopped. The patient was on selegiline for 
Parkinson's disease for 2 years and off all medications subsequently. The 2nd episode of mania 
occurred after 7 years in January 2000. This episode of mania lasting for 2 months duration was 
treated with divalproate sodium and l-dopa for Parkinson's. Treatment emergent dyskinesia had to 
be treated with Clozapine. This unusual combination ofbipolar-l disorer (2 episodes of mania) with 
Parkinson's disease and treatment emergent dyskinesia is presented with management strategy. 
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In Parkinson's disease, where mainly 
nigrostriatal tract dopamine deficiency is present, 
mesolimbic and mesocortical pathways are also 
impaired which may be related to some of the 
psychiatric complications. Mjones (1949) studied 
262 cases revealing mental symptoms in 40% 
out of which organic (memory and intellectual 
impairment) predominated over reactive 
(depression, irritability etc.). 
In affective disorders depression is well 
established with Parkinsonism. However 
Mindham (1970) found no evidence of mania in 
a retrospective study of 89 patients. Parkinson's 
disease with mania in two patients has been seen 
in only one study of late onset mania with 
neurological comorbidities by Shulman and Satlin 
(1992). Indian studies in this regard are lacking. 
In drug induced psycotic states (levo-
dopa) visual hallucinations is the most common 
diagnosis in 6-40% patients. Goodwin (1971) 
found an incidence of hypomania in 1.5% of the 
908 patients treated with levo-dopa. Mood 
disorders due'to a general medical condition 
poses problems due to multiple coexistent 
medical disorders and who are taking 
concomitant medications. 
The case presented highlights the 
occurrence of 2 episodes of mania in a patient 
of Parkinson's, with treatment emergent 
dyskinesia ocurring both times, requiring a 
consultation liaison for the management. 
CASE REPORT 
K.S. a 53 year old non-alcoholic, non-
smoker, married male a known case of non-
insulin dependent diabetes melntus. with a family 
history suggestive of a probable late onset mania 
in father, was brought in our OPD with features 
of singing songs, excessive talking, hyper-
religiosity, decreased need for sleep with 
increased appetite of one month duration Also 
tremors, rigidity, decreased mobility were 
present. This was the second episode of altered 
behaviour in Jan 2000. 
The first episode of altered behaviour was 
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in Dec. 1993. Two months before this altered 
behaviour, the patient had shown evidence of 
early Parkinson's features in the form of right 
sided tremors. However the patient had not taken 
any medications for the same. The first episode 
had stressors like father's death with a resultant 
will which was unsatisfactory along with 
monetary loss and maternal ill-health. 
During this manic episode he was talking 
excessively, appeared happy, with decreased 
sleep, increased appetite, increased goal 
directed activity, and over familiarity. This had 
lasted for 1 & 1/2 months when patient was 
treated with anti-psychotic medications. One 
month later, he developed a cerebrovascular 
accident with right hemiplegia. It took 6 months 
for recovery during which he continued receiving 
haloperidol liquid for behavioural symptoms of 
restlessness and agitation. 
In August 1994, the patient developed 
severe tardive dyskinesias for which all anti-
psychotic drugs were stopped as no behavioural 
or mood symptoms were present then. The 
patient was started on anti-parkinsonian 
medication-Selegiline. For subsequent two years 
patient was maintained to 90% pre-morbid 
functioning (10% physical complaints and 
stiffness). The patient discontinued all 
medications for three years from 1996-99 
including the anti-parkinsonian medications. 
The parkinsonian features increased in 
severity in Sept. 1999 when upon visiting a 
neurologist patient was started on a combination 
of l-dopa +c-dopa The patient developed severe 
oral dyskinesias. After four months of treatment 
the patient was advised to discontinue the same 
because of the severity of the dyskinesias. About 
15 days later, the current (2nd) episode of manic 
symptoms with severe Parkinson's disease 
started simultaneously. 
The patient was un - manageable at home 
and so brought to hospital and admitted as an 
inpatient for a month. On physical examination, 
parkinsonian features were found and the severity 
grade on Hoehn and Yahr's scale was grade IV/V 
indicating a bilateral involvement with postural 
instability and patient requiring substantial help. 
The mental state on first day had revealed 
punning, rhyming and singing songs with 
disinhibition in talks, mood as elated, affect 
expansive in range but labile, grandiose delusions 
of ability, and impaired social judgement, but did 
not show any perceptual disturbances or any 
cognitive deficits. Insight was absent. 
A diagnosis of bipolar-l disorder 2
n
d episode 
mania was made on DSM-IV multiaxial system, 
along with Idiopathic Parkinson's disease. 
Routine investigations (including blood 
sugars) before and after treatment were within 
normal range. A MRI brain, 2-D echo, ECG, were 
normal. 
In view of mania and parkinson's disease 
the patient was started on mood stabiliser 
divalproate-sodium (200 mg), which was 
subsequently increased (1000 mg) for his 
behavioural control. The patient wss also started 
on l-dopa+carbidopa (100 mg) increased further 
(500 mg) for his parkinsons. The patient 
developed severe l-dopa induced tongue 
protrusive dyskinesias, for which clozapine (25 
mg) was added as advised by the neurologist. 
The dyskinesias responded to clozapine. 
The parkinsonian symptoms decreased in 
a week's period and the drug induced dyskinesias 
decreased after clozapine was added from 
agrade of 6/6 to 1/6. The patient being a known 
case of non-insulin dependent diabetes, the oral 
hypoglycemic agent, (glipizide+metformin), was 
continued on the same doses. 
The patient was monitored using the 
following : 
Daily nurses observation scale for in 
patient evaluation (NOSIE) showed progressive 
improvement. The patient did not have any 
cognitive deficits as mini mental state 
examination scores remained at 29/30 during 
his hospital stay. Weekly abnormal involuntary 
movement scale showed decreased score and 
extra-pyramidal system rating scale decreased 
from 43/48 to 11/48. Hoehn and Yahr's scale for 
Parkinsons disease was 4/5 on admission, it 
improved to 1/5. 
At the time of discharge, which was a month 
later, the patient was still cheerful, not elated, with 
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no features of delusions of grandiose, and a grade 
I IV insight. The manic symptoms took a month to 
improve with 80-90% improvement. His, Young's 
Mania Rating Scale showed a fall from 53/60 to 
6/60. the parkinsons status showed improvement. 
There was no evidence of dyskinesias. 
To conclude the 1 st episode of mania was 
treated with haloperidol and parkinson's with 
selegiline. However the emergence of 
dyskinesias resulted in withdrawal of haloperidol 
with continuation of selegiline for parkinson's. 
The 2nd episode of mania had to be treated with 
sodium - valproate to avoid dyskinesia however 
the use of l-dopa for parkinson's with emergent 
dyskinesias necessitated the use of clozapine 
with a close consultation liaison management 
with physician and neurologist. 
DISCUSSION 
Parkinsons disease which is a low 
dopaminergic state and mania which is a high 
r dopaminergic state is a very unusual combination 
although impaired serotonergic mechanism are 
also known to play a role. In the case presented 
above the patient had features of parkinson's 
disease with 2 episodes of mania with complete 
remission of manic symptoms in between. 
Another emergent feature was l-dopa induced 
dyskinesias. Clozapine in low doses was started 
by the neurologist for dyskinesias. 
In this case because of the severity of 
parkinsons disease we clearly tried to avoid 
routine anti-psychotic drugs and we opted for 
mood stabiliser divalproate, which showed very 
good results. In recent studies atypical 
antipsychotics like clozapine, olanzapine', and 
quetiapine have shown good results drug in 
(l-dopa) induced psychosis. 
In one case report, by Vaidya & Choudhary 
(1988), a successful treatment of a known case 
of bipolar disorder with mania with parkinson's 
disease developing later, was treated with 
electro-convulsive treatment with good results. 
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* Correpondence 
The authors have mentioned that ECT's are 
useful when mania develops before parkinsons 
disease rather than after. 
Secondary mania in both neurologic and 
geriatric literature exists. Whether this case 
befitted such a secodary mania considering the 
multiple comorbid medical illnesses like stroke 
and diabetes. Nissenbaun and Quinn (1987) 
have described a "On" and "Off phenomenon 
known with l-dopa treatment, where by, hyper 
kinesias and bradykinesias occur respectively 
which is a problem in the management. Although 
the management of mood elevation caused by 
anti-parkinsonian drugs is described, there is 
dearth of literature on the management of mania 
in the case of parkinsons disease. 
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